Calcium Carbonate Microtablets via Prerefrigeration and Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to produce monodisperse, nonagglomerated microparticles of calcium carbonate with the unique morphology of perfect tablets or pills, which are rare in nature and have not been achieved synthetically.
Innovation Solution
Prerefrigerating an aqueous solution of calcium ions, gelatin, and urea, then aging it at 70°C, results in monodisperse biphasic vaterite-calcite microtablets with a unique morphology, comprising about 93 to 98% vaterite and 2 to 7% calcite, whereas without prerefrigeration, only single-phase calcite particles are formed.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional calcium carbonate synthesis methods are used, then production is simple and fast, but monodisperse nonagglomerated microparticles with tablet morphology cannot be achieved
Solution Approach 1:
The solution is prerefrigerated at 4°C for 24 hours before aging to induce controlled nucleation and prevent agglomeration, achieving monodisperse microtablets without complex equipment
Solution Approach 2:
Temperature parameters are precisely controlled (refrigeration at 4°C, aging at 70°C) to achieve phase transformation from amorphous calcium carbonate to vaterite-calcite microtablets with specific morphology
2Shape
If vaterite is produced, then spherical particles are formed, but the least stable polymorph is obtained which readily converts to calcite
Solution Approach 1:
Prerefrigeration creates a metastable state that directs nucleation toward vaterite formation, which then transforms to a stable biphasic vaterite-calcite mixture during controlled aging
Solution Approach 2:
The process exploits phase transitions from amorphous calcium carbonate through vaterite to a stable biphasic vaterite-calcite mixture, achieving both desired morphology and long-term stability
3Productivity
If amorphous calcium carbonate forms first, then transformation to vaterite and calcite occurs within minutes to hours at room temperature, but control over final morphology and phase composition is lost
Solution Approach 1:
Prerefrigeration before aging pre-conditions the solution to control the nucleation sequence and phase transformation pathway, enabling precise control over final biphasic composition
Solution Approach 2:
Temperature parameters are precisely controlled (refrigeration at 4°C, aging at 70°C) to achieve phase transformation from amorphous calcium carbonate to vaterite-calcite microtablets with specific morphology
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process effectively produces monodisperse calcium carbonate microtablets with a specific size range of 1 to 8 microns, demonstrating a significant impact on particle morphology and composition, achieving a unique biphasic vaterite-calcite mixture that was previously unattainable.
Implementation Method 1
prerefrigerating the solution containing calcium, gelatin and urea
Implementation Method 2
aging it at 70°C, results in monodisperse biphasic vaterite-calcite microtablets
Implementation Method 3
carbonation of the calcium ion (Ca2+)—aqueous solution of a calcium salt in general—by the carbonate (CO3) ion
Implementation Method 4
prerefrigerating the solution containing calcium, gelatin and urea
Data Source
AI summary
The invention discloses a method of preparing monodisperse microtablets of calcium carbonate in aqueous solutions containing calcium, gelatin and urea. Calcium carbonate powders of a unique tablet-like morphology were produced by simply ageing the prerefrigerated (at 4° C. for at least 24 hours) CaCI2-gelatin-urea solutions at 70° C. for 24 h in ordinary glass media bottles. Thermal decomposition of dissolved urea was used to supply aqueous carbonate (CO32−) ions to the calcium (Ca2+) ion and gelatin-containing solutions. Monodisperse CaCO3 microtablets have the particle sizes from 1 to 8 microns. CaCO3 microtablets were biphasic in nature and consist of 93 to 98% vaterite and 2 to 7% calcite. Identical solutions used without prerefrigeration yielded only trigonal prismatic calcite crystals upon ageing at 70° C. for 24 h.